Document is current
Any future updates will be listed below
-
Authors
Smith, Justin https://orcid.org/0009-0003-6039-5665
Hans, Varinder https://orcid.org/0000-0002-8666-5673
Yacyshyn, Elaine https://orcid.org/0000-0002-2753-2790
Rouhi, Azin https://orcid.org/0009-0001-1228-0623
Oliver, Monika https://orcid.org/0000-0002-0826-1649
- License Information
-
More Information
Article History
Received: 7 January 2024
Accepted: 9 February 2024
First Online: 19 March 2024
Declarations
:
: All authors have completed the “Conflict of Interest Disclosure Form”. The authors JS, VH, EY, and AZ declare no financial relationships with any organizations that might have an interest in the submitted work in the previous three years, no other relationships or activities that could appear to have influenced the submitted work. MO declares advisory board honoraria from Alexion, Takeda, Sobi, Novartis, Sanofi, Roche, travel support from Alexion and Sobi, speaking honoraria from Alexion and Roche, and the following clinical trial involvement: Alexion (ALXN1210-301, ALXN2040-301); Apellis (APL2-307).
